Addressing Risks Associated with IV Push Medication Use in Adults

Experts will address the variability of practice with IV push medication use, including unnecessary unit-based preparation and dilution and unsafe injection practices, highlighting strategies necessary for the mitigation of risk.

Advancing Personalized Treatment of Patients with Hemophilia Through Comprehensive Pharmacokinetic Assessment

This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.

Emerging Practices in the Management of Community-Acquired Bacterial Pneumonia

This continuing education activity will explore the current prevalence and burden of CABP, discuss practice considerations in the use of rapid diagnostics, and examine studies and data surrounding the use of antibiotics currently available as well as emerging agents in the pipeline.

Examining Strategies to Manage Antimicrobial Resistance Mechanisms

This activity will discuss mechanisms of resistance, management strategies for highlighted community and hospital-acquired infectious diseases with the most resistance-related concerns, and substitute therapeutic options when guideline or protocol-directed therapies are found to be ineffective.

Expert Perspectives in Pulmonary Arterial Hypertension: Health-System Considerations

This activity will provide health-system pharmacists and nurses and specialty pharmacyprofessionals with the foundational knowledge needed to manage PAH patients. Currentand emerging treatments will be discussed along with their place in therapy, dosing,and monitoring strategies.

Introduction to Diagnostic Stewardship

Topics will include an overview of diagnostic stewardship from a clinical laboratory perspective, including review of important diagnostics that have an impact on patient outcomes. A review of the linkages between diagnostics and enhancing antimicrobial stewardship will be provided.

Management and Trends in Pulmonary Arterial Hypertension

This activity will provide learners with foundational knowledge of PAH, including the role of several unique pathways.

MS-101: Pathogenesis, Diagnostic and Clinical Course Treatment Considerations in MS (A CSPE Core Curriculum Series)

This activity provides an introduction to MS pathology, epidemiology, and symptom management to specialty pharmacists and nurses.

MS-102: Navigating the MS Therapeutic Landscape (A CSPE Core Curriculum Series)

This activity provides an introduction to MS pathology, epidemiology, and symptom management to specialty pharmacists and nurses.

MS-103: The Role of the Specialty Pharmacy Professional in Managing MS Treatment: Care Transitions, Patient Education/Adherence, and Financial Considerations (A CSPE Core Curriculum Series)

As the third installment in the four-module NASP/CSPE MS Core Curriculum Series, this activity discusses the transitions of care, patient adherence strategies and financial considerations in the management of MS.